NA
GMED icon

NewEdge Advisors’s Globus Medical GMED Stock Holding History

NewEdge Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15M Buy
39,810
+9,270
+30% +$788K 0.01% 985
2026
Q1 		$2.63M Buy
30,540
+5,091
+20% +$457K 0.01% 960
2025
Q4 		$2.22M Buy
25,449
+17,970
+240% +$1.36M 0.01% 1019
2025
Q3 		$428K Buy
7,479
+275
+4% +$15.8K ﹤0.01% 1929
2025
Q2 		$425K Buy
7,204
+1,579
+28% +$102K ﹤0.01% 1795
2025
Q1 		$412K Sell
5,625
-284
-5% -$23.5K ﹤0.01% 1696
2024
Q4 		$489K Buy
5,909
+1,166
+25% +$92K ﹤0.01% 1571
2024
Q3 		$339K Buy
4,743
+288
+6% +$20.3K ﹤0.01% 1726
2024
Q2 		$305K Buy
4,455
+4,142
+1,323% +$247K ﹤0.01% 1710
2024
Q1 		$16.8K Sell
313
-459
-59% -$24.7K ﹤0.01% 2687
2023
Q4 		$41.1K Buy
772
+415
+116% +$20.2K ﹤0.01% 2286
2023
Q3 		$17.7K Sell
357
-41
-10% -$2.29K ﹤0.01% 2411
2023
Q2 		$23.7K Sell
398
-5,069
-93% -$289K ﹤0.01% 2333
2023
Q1 		$310K Sell
5,467
-347
-6% -$22.3K ﹤0.01% 1364
2022
Q4 		$414K Buy
5,814
+211
+4% +$14.4K 0.01% 864
2022
Q3 		$334K Buy
5,603
+390
+7% +$23.5K 0.01% 1149
2022
Q2 		$292K Buy
+5,213
New +$343K ﹤0.01% 1229
2022
Q1 		– Sell
-3,166
Closed -$229K – 1343
2021
Q4 		$229K Buy
+3,166
New +$230K ﹤0.01% 1462
2020
Q4 		– Sell
-8,233
Closed -$408K – 1030
2020
Q3 		$408K Buy
8,233
+472
+6% +$24.3K 0.01% 636
2020
Q2 		$370K Buy
7,761
+1,360
+21% +$65.6K 0.01% 620
2020
Q1 		$272K Buy
+6,401
New +$316K 0.01% 628

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

NewEdge Advisors's GMED Position: Q2 2026 in Review

NewEdge Advisors increased its Globus Medical (GMED) stake by 30% in Q2 2026, buying an estimated $788K and bringing the position to 39,810 shares worth $3.15M. The position accounts for 0.01% of the portfolio, ranked #985.

NewEdge Advisors first reported a position in GMED in Q1 2020 and has held it in 21 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • NewEdge Advisors held 39,810 shares of Globus Medical worth $3.15M as of Q2 2026.
  • NewEdge Advisors bought 9,270 Globus Medical shares in Q2 2026, an estimated $788K.
  • Globus Medical made up 0.01% of NewEdge Advisors's portfolio in Q2 2026, its #985 holding.
  • NewEdge Advisors first reported a position in Globus Medical in Q1 2020 and has held it in 21 quarters since.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.